Neurofibromatosis: New Clinical Challenges in the Era of COVID-19
Rare diseases constitute a wide range of disorders thus defined for their low prevalence. However, taken together, rare diseases impact a considerable percentage of the world population, thus representing a public healthcare problem. In particular, neurofibromatoses are autosomal-dominant genetic di...
Main Authors: | Alessio Ardizzone, Anna Paola Capra, Michela Campolo, Alessia Filippone, Emanuela Esposito, Silvana Briuglia |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/5/940 |
Similar Items
-
Awareness and agreement with neurofibromatosis care guidelines among U.S. neurofibromatosis specialists
by: Vanessa L. Merker, et al.
Published: (2022-02-01) -
Mental Pain in Patients with Neurofibromatosis and Its Association with Disease Severity
by: Reyhaneh Norouzi, et al.
Published: (2024-06-01) -
Neurofibromatosis type 1, pheochromocytoma with primary hyperparathyroidism: A rare association
by: Kishore Kumar Behera, et al.
Published: (2013-01-01) -
Neurofibromatosis type 1: a single center's experience in Korea
by: Min Jeong Kim, et al.
Published: (2014-09-01) -
Caracterización clínica de pacientes con neurofibromatosis segmentaria Clinical characterization of patients with segmental neurofibromatosis
by: Miladys Orraca Castillo, et al.
Published: (2012-04-01)